International Board of Directors Elections

ISPE International Board of Directors Election Process

The ISPE International Board of Directors 2020 Election is now open through 18 September 2020. Ballots will be emailed to all ISPE Members eligible to vote. The email contains a personal URL to access the ballot, review the nomination materials, and to cast your vote online. The personal URL can be used only once, and it can be used only by the Member to whom it was assigned.

Voting Instructions

If you encounter an error during the voting process, please contact Keith Wier, Account Manager, Intelliscan, Inc. by telphone or email. Candidates have been selected by the Nominating Committee and then approved by the ISPE Board of Directors as required in ISPE’s bylaws. We now present the nominees to you for your consideration.

  • Your ballot instructions will indicate that you can vote for one person for each Officer position and five people for the Director positions. This could be either votes for candidates listed, write in votes for any other ISPE Member, or a combination.
  • The ballot is structured differently this year. To ensure that our Board reflects the ISPE membership demographics, the Nominating Committee designed a paired slate to ensure representation from the Eastern United States, Mid and Western United States, Europe, and Asia.
  • You will vote for one Director candidate per regional category, and you will also have one additional vote to be used within any of the regional categories, for a total of five (5) votes.

Directors are elected to a two-year term and can serve up to two terms consecutively. The officer positions on the ballot are Chair, Vice Chair, Treasurer, and Secretary. The current Chair automatically becomes Past Chair in the next year and the President serves as a non-voting ex-officio member. Terms for officers are one year and the Secretary is the first officer position in the typical officer succession. Each candidate for secretary is typically making a five-year commitment to serve in the roles of Secretary through Past Chair.

All voting must be completed no later than 11:59 PM Eastern Daylight Time, Friday, 18 September 2020.

View the current ISPE International Board of Directors.


Meet the 2020 Candidates

Officer Candidates

Joanne R. Barrick, RPh
Advisor, Global Validation
Eli Lilly and Company
Chair
Jörg Zimmermann
Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.
Vice Chair
Michael L. Rutherford
Executive Director, Computer Systems Quality & Data Integrity
Syneos Health
Treasurer
Scott W. Billman
Global Head of Engineering
Biogen
Secretary

Director Candidates

Vivianne J. Arencibia
Independent Consultant
Arencibia Quality Compliance Associates
Seeking Second Term
Mark Birse
Vice President, Technical
Parexel
James Canterbury
Principal, Consulting
Ernst & Young LLP
Nina S. Cauchon, PhD
Director Regulatory Affairs - CMC
Amgen Inc.
Chris Chen, PhD
CEO
WuXi Biologics (Shanghai) Co., Ltd.
Seeking Second Term
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
John B. Noble, PhD
Vice President & General Manager, Life Sciences
Jacobs Engineering Group Inc
Georg Singewald, PhD
VP, Head of Global Quality Control
Genentech, A Member of the Roche Group
Hirofumi Suzuki, PhD
Senior Regulatory CMC Adviser
Bayer Yakuhin Ltd
Timothy J.N. Watson, PhD
Executive Director & Team Leader, CMC Advisory Office
Pfizer Inc

Board Appointed Director Position

In 2016, ISPE Governance Documents were updated to give the Board the authority to appoint one Director position to the Board during the established election cycle. The objective is to ensure ISPE has the appropriate diversity within the Board to execute business strategies as defined in our ISPE Strategic Plan. It is not the Board’s expectation that every election cycle will require an appointed position.

We are pleased to announce that the Board has appointed Mr. David Doleski to serve on the Board for a two-year term.

David Doleski
Compliance Head for Biologics Quality Operations
Sanofi

Ex Officio

John Clarke
Operations Lead
Pfizer
Board Young Professionals Representative (Non-voting)

Board Members Continuing a Term in 2020-2021

The following individuals have been elected to a two-year term and will be continuing their term in 2020-2021.

Frances M. Zipp
President & CEO
Lachman Consultant Services, Inc.
Becomes Past Chair 2020-2021
Ylva Ek
Chief Quality Officer (CQO)
KeyPlants AB
Lou W. Kennedy
CEO and Owner
Nephron Pharmaceuticals
Stephen C. Mahoney, JD
Senior Director, Global Quality & Compliance
Genentech, A Member of the Roche Group
Alice Redmond, PhD
Vice President, European Operations
CAI

Board Members Completing Their Service

The following individuals will complete their Board service and will officially end their term at the 2020 ISPE Annual Meeting & Expo. ISPE thanks these individuals for their dedication and commitment to the organization.

James A. Breen, Jr., PE
Vice President, Lead Biologics Expansion
Janssen Pharmaceuticals
Chair 2018 - 2019 & Past Chair 2019 - 2020
Gunter Baumgartner
Senior Vice President, Head of Global Engineering
Takeda Pharmaceuticals International AG
Christine M. V. Moore, PhD
Global Head and Executive Director, GRACS CMC Policy
Merck & Co, Inc.
LeAnna M. Pearson
Sr. Project Manager
PharmEng Technology
Caroline Rocks, CEng
Senior Principal Engineer
AbbVie, Inc.

Candidate Nomination and Selection Process

Below are the steps taken for selecting candidates to be on the ballot:

  • Each year, the global membership of ISPE are asked to provide the names of potential candidates to the ISPE Nominating Committee. Candidates are proposed on the basis of a number of considerations communicated in the call for nominations including strategic thinking, leadership skills, “business sense,” knowledge of the global pharma/biopharma industry, and the ability to commit the time and resources required to actively participate on the Board.
  • The Nominating Committee proposes a list of potential candidates for the vacancies on the Executive Committee and the International Board of Directors. The Board approves this list before the election.
  • Approved candidates are asked to confirm their willingness to stand for the election and to demonstrate that they have the support of their employer to serve.
  • Following the receipt of this information, the balloting process is arranged using an independent outside body, Intelliscan, Inc.

Intelliscan, Inc. conducts the entire election process and reports the results to the International Board of Directors.

Note: To be eligible to vote, you must have been an ISPE member in good standing on 7 August 2020.